Creative Biogene

Creative Biogene operates as a specialized contract research organization (CRO) and product supplier, offering essential tools for modern biological research and early-stage drug development. Its core offerings include custom-engineered stable cell lines, a wide array of viral particles (AAV, lentivirus, adenovirus), gene-editing kits, and recombinant proteins, positioning it as a one-stop shop for preclinical research needs. While not a therapeutic developer itself, the company's platform supports critical workflows in target validation, assay development, and vector production for gene and cell therapy. Its business model is based on providing high-margin research reagents and fee-for-service work to a broad customer base.

Integrated platform for cell line engineering, viral vector/VLP production, gene editing tools, RNA synthesis, recombinant protein expression, and assay kit development to support life science research and drug discovery.

Creative Biogene competes in the fragmented life science tools and services market against giants like Thermo Fisher and MilliporeSigma, as well as specialized CROs like VectorBuilder, GenScript, and BioCat. Its differentiation lies in its broad, integrated catalog spanning cell lines, viruses, and molecular tools, aiming to be a one-stop shop for preclinical research needs.